Randomized Clinical Trial
Copyright ©The Author(s) 2024.
World J Clin Cases. Jun 26, 2024; 12(18): 3491-3496
Published online Jun 26, 2024. doi: 10.12998/wjcc.v12.i18.3491
Table 1 compares serum levels of interleukin-4, interleukin-6, and interleukin-10 (mean ± SD)
Groups
Time
Interleukin-4 (pg/mL)
Interleukin-6 (pg/mL)
Interleukin-10 (pg/mL)
Research group (n = 64)Before treatment10.24 ± 1.1510.11 ± 1.2414.24 ± 2.15
After treatment4.11 ± 0.455.05 ± 0.477.04 ± 0.61
Control group (n = 64)Before treatment10.22 ± 1.1610.09 ± 1.2214.22 ± 2.18
After treatment6.64 ± 0.576.68 ± 0.519.64 ± 0.75
t/P value Research group (before and after treatment)39.711/0.00030.526/0.00025.773/0.000
t/P value Control group (before and after treatment)22.159/0.00020.631/0.00015.893/0.000
t/P value Between-group values (before treatment)0.098/0.9220.092/0.9270.052/0.958
t/P value Between-group values (post-treatment)27.870/0.00018.802/0.00021.515/0.000
Table 2 compares anal incontinence scores (mean ± SD)
Groups
Before surgery
7 d after surgery
14 d after surgery
21 d after surgery
28 d after surgery
Research group (n = 64)4.05 ± 0.5411.24 ± 1.157.24 ± 0.545.11 ± 0.484.05 ± 0.78
Control group (n = 64)4.03 ± 0.5511.22 ± 1.129.05 ± 0.648.24 ± 0.516.28 ± 0.81
t value0.2080.10017.29235.75315.865
P value0.8360.9210.0000.0000.000
Table 3 Comparison results of serum motilin, 5-hydroxytryptamine, and vasoactive intestinal peptide levels between groups (mean ± SD)
Groups
Time
Serum motilin (ng/L)
5-hydroxytryptamine (pg/mL)
Vasoactive intestinal peptide (pg/mL)
Research group (n = 64)Before treatment253.24 ± 25.5463.54 ± 2.1875.54 ± 5.54
After treatment312.24 ± 28.6882.54 ± 6.4548.04 ± 2.15
Control group (n = 64)Before treatment252.87 ± 25.6863.64 ± 2.1775.61 ± 5.49
After treatment284.64 ± 26.0570.55 ± 6.5458.64 ± 3.24
t/P value Research group (before and after treatment)12.291/0.00022.325/0.00037.021/0.000
t/P value Control group (before and after treatment)6.948/0.0008.023/0.00021.296/0.000
t/P value Between-group values (before treatment)0.082/0.9350.260/0.7950.072/0.943
t/P value Between-group values (post-treatment)5.699/0.00010.443/0.00021.808/0.000